Nanning Harworld Biotechnology Co., Ltd., established in October 2013, is a high-tech enterprise engaged in the R&D and production of microorganisms, enzyme preparations, and high-value compounds — including active pharmaceutical ingredients, bio products, natural extracts, dietary supplements, and food ingredients. The company operates a national engineering technology center pilot base and two provincial engineering technology centers, holds 70 national invention patents, and has won multiple provincial and ministerial science and technology progress awards, supported by a 12,000-square-meter R&D center, a bank of more than 22,000 strains, roughly 150 million yuan in R&D investment, and four modern production factories with combined annual output exceeding 900 million yuan. Continuous R&D investment allows the company to quickly launch new products and provide multi-specification customized services, and — offering CMO contract manufacturing with OEM/ODM production, FOB delivery, and T/T payment — it distributes to markets in North America and Asia.
No comments available.
Leave your rating & comment